Skip to NavigationSkip to content

News

Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include the...
Idorsia revealed its 2019 deal for its investigational epilepsy medicine was with Neurocrine Biosciences, and it is potentially worth more than $...
The FDA has moved to authorise Blueprint Medicines’ kinase inhibitor Ayvakit (avapritinib) for the treatment of unresectable or metastatic...
The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while Novo...
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has added another US approval to its repertoire with the news that FDA has awarded...
The recent pneumonia outbreak in Wuhan could potentially be a new virus, according to the World Health Organisation (WHO).
Novartis has provided a burst of new data directly comparing its therapy ligelizumab with the current standard of care Xolair (omalizumab), also...
A study led by the University of Warwick found that sitagliptin, a diabetes drug, could be used to treat recurrent miscarriage by targeting the...
The overall cancer mortality rate in the US fell by 2.2% from 2016 to 2017, the largest ever annual decline recorded by the American Cancer Society...
Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine for the prevention...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches